Acumen Pharmaceuticals
ABOS
ABOS
80 hedge funds and large institutions have $44.8M invested in Acumen Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 15 increasing their positions, 33 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
80
Holders Change
+1
Holders Change %
+1.27%
% of All Funds
1.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
15
Reduced
33
Closed
9
Calls
$45K
Puts
$67K
Net Calls
-$22K
Net Calls Change
+$115K
Top Buyers
| 1 |
Pathstone Holdings
Englewood,
New Jersey
|
+$528K |
| 2 |
Invesco
Atlanta,
Georgia
|
+$119K |
| 3 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$60.5K |
| 4 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
+$57.1K |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$45.9K |
Top Sellers
| 1 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$3.16M |
| 2 |
Millennium Management
New York
|
-$230K |
| 3 |
JPMorgan Chase & Co
New York
|
-$185K |
| 4 |
Franklin Resources
San Mateo,
California
|
-$145K |
| 5 |
Morgan Stanley
New York
|
-$125K |
